Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks

Seeking Alpha05:12

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

Benzinga03:29

Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $38

BenzingaDec 2 22:19 · Ratings

Hims & Hers Health Analyst Ratings

BenzingaDec 2 22:18 · Ratings

This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

BenzingaDec 2 22:05

Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?

BenzingaDec 1 23:48

RadNet Analyst Ratings

BenzingaNov 30 02:16 · Ratings

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaNov 30 01:35

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaNov 28 05:05

Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity

BenzingaNov 28 04:36

Glaukos Analyst Ratings

BenzingaNov 27 01:07 · Ratings

White House Announced: Biden-⁠Harris Administration Takes Latest Step to Lower Prescription Drug Costs by Proposing Expanded Coverage of Anti-Obesity Medications for Americans With Medicare and Medicaid

BenzingaNov 26 18:51

After Trump's nomination of the FDA commissioner, the supplier of "affordable weight loss drugs" Hims & Hers surged over 20%, reaching an all-time high.

"Hunterbrook Media, the institution that benchmarks against short sellers like Citron, believes that Trump's nomination of Marty Makary as the head of the usa Food and Drug Administration (FDA) could be beneficial for Hims & hers due to this appointment."

wallstreetcnNov 26 07:19

What's Going On With Hims & Hers Health Stock Monday?

BenzingaNov 26 06:16

Hims & Hers Health Shares Are Trading Higher. Strength Has Been Attributed to President-elect Donald Trump's Plans to Nominate Marty Makary to Lead the FDA.

BenzingaNov 26 03:32

Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick

Seeking AlphaNov 26 01:46

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday

BenzingaNov 25 23:21

Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?

BenzingaNov 24 23:20

Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...

BenzingaNov 22 05:10

Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed

Seeking AlphaNov 22 05:09